Deutsch English Français

Contact

EP3283070

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3283070

EP3283070 - METHODS FOR TREATING CANCER [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 24.01.2020 Database last updated on 12.11.2024
Former	Examination is in progress Status updated on 08.05.2019
Former	Request for examination was made Status updated on 19.01.2018
Former	The international publication has been made Status updated on 10.11.2017
Most recent event Tooltip	24.01.2020	Application deemed to be withdrawn	published on 26.02.2020 [2020/09]
Applicant(s)	For all designated states Boston Biomedical, Inc. 640 Memorial Drive Cambridge, MA 02139 / US
	[2018/08]
Inventor(s)	01 / LI, Chiang, J. 8 Museum Way Cambridge, MA 02141 / US
	02 / LI, Youzhi 142 Gay Street Westwood, MA 02090 / US
	03 / BORODYANSKY, Laura 45 Longwood Avenue 602 Brookline, MA 02446 / US
	04 / GAO, Yuan 23 Cowdin Street Belmont, MA 02478 / US
	05 / LEGGETT, David 5 Lincoln Street Milton, MA 02186 / US
	06 / KERSTEIN, David, P. 22 Algonquin Road North Reading, MA 01864 / US
	[2018/08]
Representative(s)	Haseltine Lake Kempner LLP Cheapside House 138 Cheapside London EC2V 6BJ / GB
	[N/P]
Former [2018/08]	FRKelly 27 Clyde Road Dublin D04 F838 / IE
Application number, filing date	16723855.9	18.04.2016
	[2018/08]
	WO2016US28179
Priority number, date	US201562149349P	17.04.2015 Original published format: US 201562149349 P
	[2018/08]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2016168858
	Date:	20.10.2016
	Language:	EN
	[2016/42]
	Type:	A1 Application with search report
	No.:	EP3283070
	Date:	21.02.2018
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 20.10.2016 takes the place of the publication of the European patent application.
	[2018/08]
Search report(s)	International search report - published on:	EP	20.10.2016
Classification	IPC:	A61K31/343, A61K39/395, A61P35/00	[2018/08]
	CPC:	A61K31/343 (EP,CN,KR,US); A61K31/282 (EP,US); A61K31/437 (CN); A61K31/44 (EP,US); A61K31/513 (EP,CN,US); A61K31/519 (EP,US); (+) A61K31/522 (CN); A61K31/7068 (EP,US); A61K39/3955 (EP,KR,US); A61P35/00 (EP,US); A61P35/04 (EP,US); C07K16/22 (EP,KR,US); C07K16/2863 (EP,KR,US); A61K2300/00 (KR); C07K2317/21 (US); C07K2317/24 (US) (-)
	C-Set:	A61K31/343, A61K2300/00 (CN,EP,US); A61K31/437, A61K2300/00 (CN); A61K31/513, A61K2300/00 (CN); A61K31/522, A61K2300/00 (CN); (+) A61K39/3955, A61K2300/00 (US,EP) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/08]
Title	German:	VERFAHREN ZUR BEHANDLUNG VON KREBS	[2018/08]
	English:	METHODS FOR TREATING CANCER	[2018/08]
	French:	MÉTHODES DE TRAITEMENT DU CANCER	[2018/08]
Entry into regional phase	09.11.2017	National basic fee paid
	09.11.2017	Designation fee(s) paid
	09.11.2017	Examination fee paid
Examination procedure	09.11.2017	Examination requested [2018/08]
	09.11.2017	Date on which the examining division has become responsible
	01.06.2018	Amendment by applicant (claims and/or description)
	13.05.2019	Despatch of a communication from the examining division (Time limit: M04)
	24.09.2019	Application deemed to be withdrawn, date of legal effect [2020/09]
	21.10.2019	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/09]
Fees paid	Renewal fee
	21.02.2018	Renewal fee patent year 03
	23.04.2019	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XDY]WO2009036101 (BOSTON BIOMEDICAL INC [US], et al) [XD] 3,17-19,23,24 * abstract * * page 5, paragraph 15 - page 7, paragraph 25 * * page 8, paragraph 31 * * page 18, paragraph 79 - paragraph 80 * * page 22, paragraph 98 - paragraph 99 * * page 24, paragraph 103 - paragraph 104 * [Y] 1-24;
		[Y]US2010297118 (MACDOUGALL JOHN [US], et al) [Y] 1-24* claims 1, 6, 7, 28-34 *;
		[Y]WO2013166618 (ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO LTD [CN], et al) [Y] 1-24 * abstract * * page 14 - page 15 * * claims 2-7 *;
		[YD]WO2014169078 (BOSTON BIOMEDICAL INC [US], et al) [YD] 1-24 * page 2, paragraph 8 - page 3 * * page 8, paragraph 27 - page 9, paragraph 29 * * claims *;
		[XP] - Anonymous, "Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types - Boston Biomedical", (20150601), pages 1 - 5, URL: http://www.bostonbiomedical.com/boston-biomedical-data-at-asco-2015-highlights-potential-of-novel-investigational-cancer-stem-cell-pathway-inhibitors-bbi608-and-bbi503-in-multiple-cancer-types/, (20160628), XP055284244 [XP] 1-24 * the whole document *
	by applicant	- GUPTA PB ET AL., NAT. MED., (2009), vol. 15, no. 9, pages 1010 - 1012
		- CLARKE MF, BIOL. BLOOD MARROW TRANSPLANT, (2009), vol. 11, no. 2, pages 14 - 16
		- JORDAN CT ET AL., N. ENGL. J. MED., (2006), vol. 355, no. 12, pages 1253 - 1261
		- BOMAN BM ET AL., J. CLIN. ONCOL., (2008), vol. 26, no. 17, pages 2828 - 2838
		- BOROVSKI T. ET AL., CANCER RES., (2011), vol. 71, no. 3, pages 634 - 639
		- PEDRANZINI, L. ET AL., J. CLIN. INVEST., (2004), vol. 114, no. 5, pages 619 - 622
		- CATLETT-FALCONE, R. ET AL., IMMUNITY, (1999), vol. 10, no. 1, pages 105 - 115
		- BROMBERG, J. F. ET AL., CELL, (1999), vol. 98, no. 3, pages 295 - 303
		- KANDA, N. ET AL., ONCOGENE, (2004), vol. 23, no. 28, pages 4921 - 4929
		- SCHLETTE, E. J. ET AL., J CLIN ONCOL, (2004), vol. 22, no. 9, pages 1682 - 1688
		- NIU, G. ET AL., ONCOGENE, (2002), vol. 21, no. 13, pages 2000 - 2008
		- XIE, T. X. ET AL., ONCOGENE, (2004), vol. 23, no. 20, pages 3550 - 3560
		- KORTYLEWSKI, M. ET AL., NAT. MED., (2005), vol. 11, no. 12, pages 1314 - 1321
		- BURDELYA, L. ET AL., J. LMMUNOL., (2005), vol. 174, no. 7, pages 3925 - 3931
		- WANG, T. ET AL., NAT. MED., (2004), vol. 10, no. 1, pages 48 - 54
		- PEDRANZINI, L. ET AL., J CLIN. INVEST., (2004), vol. 114, no. 5, pages 619 - 622
		- DARNELL, J. E., NAT. MED., (2005), vol. 11, no. 6, pages 595 - 596
		- ZHANG, L. ET AL., CANCER RES, (2007), vol. 67, no. 12, pages 5859 - 5864
		- BOMAN, B. M. ET AL., J. CLIN. ONCOL., (2008), vol. 26, no. 17, pages 2795 - 2799
		- BONNET, D.; J. E. DICK, NAT. MED., (1997), vol. 3, no. 7, pages 730 - 737
		- HAMBARDZUMYAN ET AL., CANCER CELL, (2006), vol. 10, no. 6, pages 454 - 456
		- BAUMANN, M. ET AL., NAT. REV. CANCER, (2008), vol. 8, no. 7, pages 545 - 554
		- JONES RJ ET AL., J NATL CANCER INST., (2004), vol. 96, no. 8, pages 583 - 585
		- HO, M. M. ET AL., CANCER RES., (2007), vol. 67, no. 10, pages 4827 - 4833
		- WANG, J. ET AL., CANCER RES., (2007), vol. 67, no. 8, pages 3716 - 3724
		- HARAGUCHI, N. ET AL., STEM CELLS, (2006), vol. 24, no. 3, pages 506 - 513
		- DOYLE, L. A.; D. D. ROSS, ONCOGENE, (2003), vol. 22, no. 47, pages 7340 - 7358
		- ALVI, A. J. ET AL., BREAST CANCER RES., (2003), vol. 5, no. 1, pages R1 - R8
		- FRANK, N. Y. ET AL., CANCER RES., (2005), vol. 65, no. 10, pages 4320 - 4333
		- SCHATTON, T. ET AL., NATURE, (2008), vol. 451, no. 7176, pages 345 - 349
		- KONDO, T. ET AL., PROC. NATL ACAD. SCI. USA, (2004), vol. 101, no. 3, pages 781 - 786
		- GOODELL, M. A. ET AL., J. EXP. MED., (1996), vol. 183, no. 4, pages 1797 - 1806
		- AI-HAJJ, M. ET AL., PROC. NATL ACAD. SCI. USA, (2003), vol. 100, no. 7, pages 3983 - 3988
		- COLLINS, A. T. ET AL., CANCER RES., (2005), vol. 65, no. 23, pages 10946 - 10951
		- LI, C. ET AL., CANCER RES., (2007), vol. 67, no. 3, pages 1030 - 1037
		- MA, S. ET AL., GASTROENTEROLOGY, (2007), vol. 132, no. 7, pages 2542 - 2556
		- RICCI-VITIANI, L. ET AL., NATURE, (2007), vol. 445, no. 7123, pages 111 - 115
		- SINGH, S. K. ET AL., CANCER RES., (2003), vol. 63, no. 18, pages 5821 - 5828
		- BLEAU, A. M. ET AL., NEUROSURG. FOCUS, (2008), vol. 24, no. 3-4, page E28
		- J. PHARMACEUTICAL SCIENCES, (1977), vol. 66, pages 1 - 19

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p